243 related articles for article (PubMed ID: 30045758)
1. Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network.
Karch CM; Hernández D; Wang JC; Marsh J; Hewitt AW; Hsu S; Norton J; Levitch D; Donahue T; Sigurdson W; Ghetti B; Farlow M; Chhatwal J; Berman S; Cruchaga C; Morris JC; Bateman RJ; ; Pébay A; Goate AM
Alzheimers Res Ther; 2018 Jul; 10(1):69. PubMed ID: 30045758
[TBL] [Abstract][Full Text] [Related]
2. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
[TBL] [Abstract][Full Text] [Related]
3. Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.
Ringman JM; Monsell S; Ng DW; Zhou Y; Nguyen A; Coppola G; Van Berlo V; Mendez MF; Tung S; Weintraub S; Mesulam MM; Bigio EH; Gitelman DR; Fisher-Hubbard AO; Albin RL; Vinters HV
J Neuropathol Exp Neurol; 2016 Mar; 75(3):284-90. PubMed ID: 26888304
[TBL] [Abstract][Full Text] [Related]
4. Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease.
Gao Y; Ren RJ; Zhong ZL; Dammer E; Zhao QH; Shan S; Zhou Z; Li X; Zhang YQ; Cui HL; Hu YB; Chen SD; Chen JJ; Guo QH; Wang G
Neurobiol Aging; 2019 May; 77():154-157. PubMed ID: 30822634
[TBL] [Abstract][Full Text] [Related]
5. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
[TBL] [Abstract][Full Text] [Related]
6. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
[TBL] [Abstract][Full Text] [Related]
7. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
Pimenova AA; Goate AM
Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
[TBL] [Abstract][Full Text] [Related]
8.
Giau VV; Bagyinszky E; Youn YC; An SSA; Kim S
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557888
[TBL] [Abstract][Full Text] [Related]
9. Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2.
Hsu S; Pimenova AA; Hayes K; Villa JA; Rosene MJ; Jere M; Goate AM; Karch CM
Neurobiol Dis; 2020 Jun; 139():104817. PubMed ID: 32087291
[TBL] [Abstract][Full Text] [Related]
10. Seizures in dominantly inherited Alzheimer disease.
Zarea A; Charbonnier C; Rovelet-Lecrux A; Nicolas G; Rousseau S; Borden A; Pariente J; Le Ber I; Pasquier F; Formaglio M; Martinaud O; Rollin-Sillaire A; Sarazin M; Croisile B; Boutoleau-Bretonnière C; Ceccaldi M; Gabelle A; Chamard L; Blanc F; Sellal F; Paquet C; Campion D; Hannequin D; Wallon D;
Neurology; 2016 Aug; 87(9):912-9. PubMed ID: 27466472
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing in a presenilin 2 variant associated with Alzheimer disease.
Braggin JE; Bucks SA; Course MM; Smith CL; Sopher B; Osnis L; Shuey KD; Domoto-Reilly K; Caso C; Kinoshita C; Scherpelz KP; Cross C; Grabowski T; Nik SHM; Newman M; Garden GA; Leverenz JB; Tsuang D; Latimer C; Gonzalez-Cuyar LF; Keene CD; Morrison RS; Rhoads K; Wijsman EM; Dorschner MO; Lardelli M; Young JE; Valdmanis PN; Bird TD; Jayadev S
Ann Clin Transl Neurol; 2019 Apr; 6(4):762-777. PubMed ID: 31020001
[TBL] [Abstract][Full Text] [Related]
12. Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations.
Wong TH; Seelaar H; Melhem S; Rozemuller AJM; van Swieten JC
Neurobiol Aging; 2020 Feb; 86():201.e9-201.e14. PubMed ID: 30797548
[TBL] [Abstract][Full Text] [Related]
13. Discovery and validation of dominantly inherited Alzheimer's disease mutations in populations from Latin America.
Takada LT; Aláez-Verson C; Burgute BD; Nitrini R; Sosa AL; Castilhos RM; Chaves MF; Longoria EM; Carrillo-Sánchez K; Brucki SMD; Flores-Lagunes LL; Molina C; Olivares MJ; Ziegemeier E; Petranek J; Goate AM; Cruchaga C; Renton AE; Fernández MV; Day GS; McDade E; Bateman RJ; Karch CM; Llibre-Guerra JJ;
Alzheimers Res Ther; 2022 Aug; 14(1):108. PubMed ID: 35932032
[TBL] [Abstract][Full Text] [Related]
14. A novel PSEN2 p.Ser175Phe variant in a family with Alzheimer's disease.
Guven G; Samanci B; Gulec C; Hanagasi H; Gurvit H; Gokalp EE; Tepgec F; Guler S; Uyguner O; Bilgic B
Neurol Sci; 2021 Jun; 42(6):2497-2504. PubMed ID: 33855622
[TBL] [Abstract][Full Text] [Related]
15. Impaired default network functional connectivity in autosomal dominant Alzheimer disease.
Chhatwal JP; Schultz AP; Johnson K; Benzinger TL; Jack C; Ances BM; Sullivan CA; Salloway SP; Ringman JM; Koeppe RA; Marcus DS; Thompson P; Saykin AJ; Correia S; Schofield PR; Rowe CC; Fox NC; Brickman AM; Mayeux R; McDade E; Bateman R; Fagan AM; Goate AM; Xiong C; Buckles VD; Morris JC; Sperling RA
Neurology; 2013 Aug; 81(8):736-44. PubMed ID: 23884042
[TBL] [Abstract][Full Text] [Related]
16. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
[TBL] [Abstract][Full Text] [Related]
17. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.
Campion D; Dumanchin C; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Anterion C; Michon A; Martin C; Charbonnier F; Raux G; Camuzat A; Penet C; Mesnage V; Martinez M; Clerget-Darpoux F; Brice A; Frebourg T
Am J Hum Genet; 1999 Sep; 65(3):664-70. PubMed ID: 10441572
[TBL] [Abstract][Full Text] [Related]
18. Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease.
Sassi C; Guerreiro R; Gibbs R; Ding J; Lupton MK; Troakes C; Lunnon K; Al-Sarraj S; Brown KS; Medway C; Lord J; Turton J; Mann D; Snowden J; Neary D; Harris J; Bras J; ; Morgan K; Powell JF; Singleton A; Hardy J
Neurobiol Aging; 2014 Oct; 35(10):2422.e13-6. PubMed ID: 24880964
[TBL] [Abstract][Full Text] [Related]
19. Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease.
Schultz SA; Shirzadi Z; Schultz AP; Liu L; Fitzpatrick CD; McDade E; Barthelemy NR; Renton A; Esposito B; Joseph-Mathurin N; Cruchaga C; Chen CD; Goate A; Allegri RF; Benzinger TLS; Berman S; Chui HC; Fagan AM; Farlow MR; Fox NC; Gordon BA; Day GS; Graff-Radford NR; Hassenstab JJ; Hanseeuw BJ; Hofmann A; Jack CR; Jucker M; Karch CM; Koeppe RA; Lee JH; Levey AI; Levin J; Martins RN; Mori H; Morris JC; Noble J; Perrin RJ; Rosa-Neto P; Salloway SP; Sanchez-Valle R; Schofield PR; Xiong C; Johnson KA; Bateman RJ; Sperling RA; Chhatwal JP;
Aging Cell; 2023 Aug; 22(8):e13871. PubMed ID: 37291760
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic analysis of the APP, PSEN1, and PSEN2 genes in Finnish patients with early-onset Alzheimer disease and frontotemporal lobar degeneration.
Krüger J; Moilanen V; Majamaa K; Remes AM
Alzheimer Dis Assoc Disord; 2012; 26(3):272-6. PubMed ID: 21959359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
